AHR
Income statement / Annual
Last year (2024), American Healthcare REIT, Inc.'s total revenue was $2.07 B,
an increase of 11.38% from the previous year.
In 2024, American Healthcare REIT, Inc.'s net income was -$37.81 M.
See American Healthcare REIT, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$2.07 B |
$1.86 B |
$1.62 B |
$1.26 B |
$1.18 B |
$1.22 B |
$1.13 B |
$1.05 B |
$980.30 M |
| Cost of Revenue |
$1.65 B
|
$1.50 B
|
$1.28 B
|
$1.08 B
|
$1.03 B
|
$1.00 B
|
$923.82 M
|
$837.64 M
|
$800.10 M
|
| Gross Profit |
$416.78 M
|
$356.83 M
|
$335.97 M
|
$182.01 M
|
$158.58 M
|
$219.30 M
|
$207.56 M
|
$211.60 M
|
$180.19 M
|
| Gross Profit Ratio |
0.2
|
0.19
|
0.21
|
0.14
|
0.13
|
0.18
|
0.18
|
0.2
|
0.18
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$100.80 M
|
$104.99 M
|
$103.10 M
|
$43.20 M
|
$27.01 M
|
$29.75 M
|
$28.42 M
|
$32.17 M
|
$28.68 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$100.80 M
|
$104.99 M
|
$103.10 M
|
$43.20 M
|
$27.01 M
|
$29.75 M
|
$28.42 M
|
$32.17 M
|
$28.68 M
|
| Other Expenses |
$179.19 M
|
$175.13 M
|
$142.28 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$279.99 M
|
$280.11 M
|
$245.38 M
|
$43.20 M
|
$27.01 M
|
$29.75 M
|
$28.42 M
|
$32.17 M
|
$28.68 M
|
| Cost And Expenses |
$1.93 B
|
$1.78 B
|
$1.53 B
|
$1.13 B
|
$1.05 B
|
$1.03 B
|
$952.24 M
|
$869.82 M
|
$828.78 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$127.73 M
|
$163.19 M
|
$105.96 M
|
$80.94 M
|
$71.28 M
|
$78.55 M
|
$66.28 M
|
$60.87 M
|
$45.67 M
|
| Depreciation & Amortization |
$221.64 M
|
$237.30 M
|
$200.60 M
|
$153.81 M
|
$132.43 M
|
$140.12 M
|
$96.27 M
|
$113.63 M
|
$272.21 M
|
| EBITDA |
$315.48 M |
$324.26 M |
$233.76 M |
$159.43 M |
$165.14 M |
$218.26 M |
$179.38 M |
$179.41 M |
$152.15 M |
| EBITDA Ratio |
0.15
|
0.17
|
0.14
|
0.13
|
0.14
|
0.18
|
0.16
|
0.17
|
0.16
|
| Operating Income Ratio |
0.07
|
0.04
|
0.06
|
0.11
|
0.11
|
0.16
|
0.16
|
0.17
|
0.15
|
| Total Other Income/Expenses Net |
-$170.67 M
|
-$152.94 M
|
-$163.39 M
|
-$191.12 M
|
-$125.79 M
|
-$190.41 M
|
-$165.40 M
|
-$177.30 M
|
-$355.07 M
|
| Income Before Tax |
-$33.89 M
|
-$76.22 M
|
-$72.80 M
|
-$52.31 M
|
$5.79 M
|
-$860.00 K
|
$13.74 M
|
$2.12 M
|
-$203.55 M
|
| Income Before Tax Ratio |
-0.02
|
-0.04
|
-0.05
|
-0.04
|
0
|
-0
|
0.01
|
0
|
-0.21
|
| Income Tax Expense |
$1.71 M
|
$663.00 K
|
$586.00 K
|
$956.00 K
|
-$3.08 M
|
-$8.00 K
|
$8.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$37.81 M
|
-$71.47 M
|
-$81.30 M
|
-$47.79 M
|
$2.16 M
|
-$4.97 M
|
$13.30 M
|
$11.22 M
|
-$146.03 M
|
| Net Income Ratio |
-0.02
|
-0.04
|
-0.05
|
-0.04
|
0
|
-0
|
0.01
|
0.01
|
-0.15
|
| EPS |
-0.29 |
-1.08 |
-1.23 |
-0.72 |
0.0327 |
-0.11 |
0.27 |
0.23 |
-3.01 |
| EPS Diluted |
-0.29 |
-1.08 |
-1.23 |
-0.72 |
0.0327 |
-0.11 |
0.27 |
0.23 |
-3.01 |
| Weighted Average Shares Out |
$130.64 M
|
$66.05 M
|
$66.21 M
|
$66.21 M
|
$66.05 M
|
$45.48 M
|
$49.99 M
|
$49.56 M
|
$48.55 M
|
| Weighted Average Shares Out Diluted |
$130.64 M
|
$66.05 M
|
$66.21 M
|
$66.21 M
|
$66.05 M
|
$45.48 M
|
$49.99 M
|
$49.56 M
|
$48.55 M
|
| Link |
|
|
|
|
|
|
|
|
|
